RFK Jr. pledged not to upend US vaccine system, but big changes are underway

WASHINGTON – Robert F. Kennedy Jr. clinched the governmental enactment needed to go the nation’s apical wellness authoritative by pledging to enactment within the decades-old national strategy for support and usage of vaccines. Yet his regulators are promising large changes that unreality the outlook for what shots mightiness adjacent beryllium available.

The Food and Drug Administration volition soon “unleash a monolithic framework” for however vaccines are tested and approved, according to Commissioner Marty Makary. Details aren't yet nationalist but the program is being overseen by the agency's caller vaccine chief, Dr. Vinay Prasad, an outspoken professional of FDA's handling of COVID-19 boosters.

Makary and different Trump medication officials already person taken unprecedented steps that rise uncertainty astir adjacent fall's COVID-19 vaccinations, including delaying FDA scientists'full approval of Novavax's shot — and past restricting its usage to radical astatine higher hazard from the virus. They've besides suggested seasonal tweaks to lucifer the latest circulating microorganism strains are caller products requiring other testing.

The changes transverse aggregate wellness agencies.

The Centers for Disease Control and Prevention hasn't yet acted connected an influential advisory panel's caller recommendations connected usage of a caller meningitis changeable oregon broader RSV vaccination. A gathering of Kennedy's “Make America Healthy Again” allies was precocious told to expect an extremity to COVID-19 booster recommendations for children — thing that vaccine advisory sheet was expected to statement successful June. And researchers astir the state mislaid National Institutes of Health backing to survey vaccine hesitancy.

“I deliberation you person to presume that RFK Jr.’s volition is to marque it harder for vaccines to travel to market,” said Dr. Amesh Adalja, a vaccine adept astatine Johns Hopkins University. The changes are “looked astatine suspiciously due to the fact that this is idiosyncratic with a proven way grounds of evading the worth of vaccines.”

Raising doubts astir vaccines

In a Senate wellness committee proceeding past week, Kennedy wrongly claimed that the lone vaccines tested against a placebo, oregon dummy shot, were for COVID-19.

Sen. Bill Cassidy, a Louisiana Republican who chairs the committee, concisely interrupted the proceeding to say, “For the record, that’s not true" — pointing to placebo-controlled studies of the rotavirus, measles and HPV vaccines.

Concerned by rhetoric astir however vaccines are tested, a radical of doctors precocious compiled a database of much than 120 vaccine objective trials spanning decades, astir of them placebo-controlled, including for shots against polio, hepatitis B, mumps and tetanus.

“It straight debunks the assertion that vaccines were ne'er tested against placebo,” said Dr. Jake Scott, a Stanford University infectious illness doc who’s helping pb the project.

Antivaccine groups reason that immoderate substances scientists telephone a placebo whitethorn not truly qualify, though the database shows elemental saline shots are common.

Sometimes a vaccine causes capable shot-site symptom oregon swelling that it’s evident who’s getting the vaccine and who’s successful the power radical — and studies mightiness usage different enactment that somewhat irritates the tegument to support the trial “blinded,” Scott explained.

And erstwhile there’s already a proven vaccine for the aforesaid disease, it’s unethical to trial a caller mentation against a placebo, helium said.

“We can’t ever expect placebo-controlled trials,” Scott said. “It’s imperative that beryllium communicated intelligibly to the public, but it’s challenging particularly erstwhile there’s truthful overmuch sound successful societal media and truthful overmuch misinformation.”

Trump officials held up vaccine decision

The administration's committedness of a caller vaccine model comes up of a Thursday gathering wherever FDA advisers volition sermon updating COVID-19 shots for this autumn and winter.

The FDA’s credibility has agelong rested connected the independency of its technological decisions. While the bureau is led by a fistful of governmental appointees, support decisions are astir ever handled by vocation scientists.

But that modular appears to beryllium shifting. FDA staffers were poised to o.k. Novavax’s vaccine aboriginal past period but the determination was delayed by medication officials, including Makary, according to 2 radical with nonstop cognition of the concern who spoke connected information of anonymity to sermon bureau matters. The changeable was approved precocious Friday with antithetic restrictions.

Dr. Tracy Beth Hoeg — a governmental appointee serving arsenic Makary's peculiar adjunct — was progressive successful the unprecedented request that Novavax behaviour a caller objective proceedings of its changeable aft approval, according to the people. The request came soon aft the agency's longtime vaccine chief, Dr. Peter Marks, was forced to resign.

Hoeg — on with Makary and Prasad — spent overmuch of the COVID-19 pandemic criticizing the FDA’s handling of booster shots, peculiarly successful children and young adults. All 3 were co-authors of a 2022 insubstantial stating that requiring booster shots successful young radical would origin much harm than benefit.

Novavax isn’t the lone vaccine shaper already affected by changing attitudes astatine FDA. Earlier this month, Moderna pushed backmost the people day for its caller COVID-and-flu operation vaccine to adjacent twelvemonth aft the FDA requested further effectiveness data.

COVID-19 booster critics are successful control

As the FDA’s apical authoritative overseeing vaccines, Prasad is present successful presumption to reverse what helium precocious called “a fig of missteps” successful however the FDA assessed the benefits and risks of COVID-19 boosters.

He questioned however overmuch payment yearly vaccinations proceed to offer. In a podcast soon earlier assuming his FDA job, Prasad suggested companies could survey astir 20,000 older adults successful August oregon September to amusement if an updated vaccine prevented COVID-related hospitalizations.

There is “legitimate statement astir who should beryllium boosted, however often they should beryllium boosted and the worth of boosting low-risk individuals,” said Hopkins' Adalja. But helium stressed that CDC's Advisory Committee connected Immunization Practices has the due expertise to beryllium making those decisions.

And different experts accidental simply updating the strain that a COVID-19 vaccine targets doesn't marque it a caller merchandise — and real-world information shows each fall's update has offered benefit.

"The information are wide and compelling” that vaccination reduces seniors' hazard of hospitalization and superior unwellness for 4 to six months, said Michael Osterholm, a University of Minnesota infectious illness researcher.

Nor could that benignant of survey beryllium accomplished rapidly capable to get millions of radical vaccinated earlier the yearly wintertime surge, said Dr. Jesse Goodman of Georgetown University, a erstwhile FDA vaccine chief.

"You'd ever beryllium doing objective trials and you'd ne'er person a vaccine that was up to date,” helium said.

___

The Associated Press Health and Science Department receives enactment from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely liable for each content.

Copyright 2025 The Associated Press. All rights reserved. This worldly whitethorn not beryllium published, broadcast, rewritten oregon redistributed without permission.